Tom Powles, Director of Barts Cancer Center, shared a post on X:
“40% response rate for chemotherapy + pembro in advanced penile cancer.
(cORR 55.6%) and TMB-high (cORR 75%) potentially enrich. A great investigator-initiated study from LACOG and Fernando Maluf. ”
Source: Tom Powles/X